Provention Bio Inc
PRVB
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.38B
Close$
$26.22
5% upside
Current Fair Value
5% upsideUndervalued by 5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.38 Billion |
|---|---|
| Enterprise Value | $2.37 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.52 |
| Beta | 2.46 |
| Outstanding Shares | 74,723,000 |
Return
| Return on Equity | -92.72% |
|---|---|
| Return on Assets | -47.70% |
| Return on Invested Capital | -87.50% |
Valuation & Multiples
| P/E Ratio | -16.44 |
|---|---|
| PEG | -56.99 |
| Price to Sales | - |
| Price to Book Ratio | 24.98 |
| Enterprise Value to Revenue | 184.02 |
| Enterprise Value to EBIT | -18.52 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Provention Bio Inc
CEO: Ashleigh Palmer